KR20240145992A - 비사이클릭 프탈라진-1(2h)-온 유도체 및 관련 용도 - Google Patents
비사이클릭 프탈라진-1(2h)-온 유도체 및 관련 용도 Download PDFInfo
- Publication number
- KR20240145992A KR20240145992A KR1020247026276A KR20247026276A KR20240145992A KR 20240145992 A KR20240145992 A KR 20240145992A KR 1020247026276 A KR1020247026276 A KR 1020247026276A KR 20247026276 A KR20247026276 A KR 20247026276A KR 20240145992 A KR20240145992 A KR 20240145992A
- Authority
- KR
- South Korea
- Prior art keywords
- alkyl
- compound
- cycloalkyl
- disease
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263297444P | 2022-01-07 | 2022-01-07 | |
| US63/297,444 | 2022-01-07 | ||
| PCT/US2023/010314 WO2023133271A1 (en) | 2022-01-07 | 2023-01-06 | Bicyclic phthalazin-1(2h)-one derivatives and related uses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20240145992A true KR20240145992A (ko) | 2024-10-07 |
Family
ID=85239129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020247026276A Pending KR20240145992A (ko) | 2022-01-07 | 2023-01-06 | 비사이클릭 프탈라진-1(2h)-온 유도체 및 관련 용도 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250066369A1 (https=) |
| EP (1) | EP4460505A1 (https=) |
| JP (1) | JP2025504374A (https=) |
| KR (1) | KR20240145992A (https=) |
| CN (1) | CN118922421A (https=) |
| AU (1) | AU2023205048A1 (https=) |
| CA (1) | CA3247232A1 (https=) |
| IL (1) | IL314035A (https=) |
| MX (1) | MX2024008477A (https=) |
| WO (1) | WO2023133271A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025153532A1 (en) * | 2024-01-16 | 2025-07-24 | NodThera Limited | Nlrp3 inhibitors and glp-1 agonists combination therapies |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
| RU2364597C1 (ru) * | 2007-12-14 | 2009-08-20 | Андрей Александрович Иващенко | ГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ Hh-СИГНАЛЬНОГО КАСКАДА, ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НА ИХ ОСНОВЕ И СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С АББЕРАНТНОЙ АКТИВНОСТЬЮ Hh СИГНАЛЬНОЙ СИСТЕМЫ |
| CN116194445A (zh) * | 2020-09-24 | 2023-05-30 | 詹森药业有限公司 | 新化合物 |
-
2023
- 2023-01-06 CN CN202380025701.8A patent/CN118922421A/zh active Pending
- 2023-01-06 WO PCT/US2023/010314 patent/WO2023133271A1/en not_active Ceased
- 2023-01-06 EP EP23705320.2A patent/EP4460505A1/en active Pending
- 2023-01-06 IL IL314035A patent/IL314035A/en unknown
- 2023-01-06 MX MX2024008477A patent/MX2024008477A/es unknown
- 2023-01-06 US US18/726,919 patent/US20250066369A1/en active Pending
- 2023-01-06 KR KR1020247026276A patent/KR20240145992A/ko active Pending
- 2023-01-06 AU AU2023205048A patent/AU2023205048A1/en active Pending
- 2023-01-06 CA CA3247232A patent/CA3247232A1/en active Pending
- 2023-01-06 JP JP2024540866A patent/JP2025504374A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3247232A1 (en) | 2023-07-13 |
| US20250066369A1 (en) | 2025-02-27 |
| IL314035A (en) | 2024-09-01 |
| WO2023133271A1 (en) | 2023-07-13 |
| CN118922421A (zh) | 2024-11-08 |
| JP2025504374A (ja) | 2025-02-12 |
| AU2023205048A1 (en) | 2024-07-18 |
| MX2024008477A (es) | 2024-08-30 |
| EP4460505A1 (en) | 2024-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102735310B1 (ko) | Nlrp3 인플라마좀 조절제로서의 설포닐 우레아 유도체 | |
| JP7054529B2 (ja) | Ｃｘｃｒ４阻害剤およびその使用 | |
| JP7084624B2 (ja) | Ｃｘｃｒ４阻害剤およびその使用 | |
| TW201910306A (zh) | Nlrp3發炎體之選擇性抑制劑 | |
| CN111406063B (zh) | 作为抗癌剂的环二核苷酸 | |
| JP2021073298A (ja) | ピリミジニルチロシンキナーゼ阻害剤 | |
| JP2019528301A (ja) | インドールアミン２，３−ジオキシゲナーゼの阻害剤およびその使用方法 | |
| JP7661248B2 (ja) | スルホニル尿素誘導体及びその使用 | |
| JP2021519316A (ja) | Ｔｌｒ２シグナル伝達の調節剤としての化合物 | |
| KR20230061505A (ko) | 알킬-옥사사이클로알킬 모이어티를 함유하는 설파모일 우레아 유도체 및 이의 용도 | |
| US20260008780A1 (en) | Substituted 3,4-dihydroisoquinolin-1(2h)-one derivatives and related uses | |
| CN113286786A (zh) | Nlrp3调节剂 | |
| KR20200140262A (ko) | Tcr-nck 상호 작용의 억제제로서의 크로멘 유도체 | |
| JP7682813B2 (ja) | スルホニル尿素誘導体及びその使用 | |
| JP2022535955A (ja) | スルホンアミド誘導体及びその使用 | |
| KR20240145992A (ko) | 비사이클릭 프탈라진-1(2h)-온 유도체 및 관련 용도 | |
| TWI916398B (zh) | 含有烷基－氧雜環烷基部分之胺磺醯基脲衍生物及其用途 | |
| RU2858266C2 (ru) | Производные сульфамоилмочевины, содержащие алкилоксациклоалкильную группу, и их применения | |
| US20250206745A1 (en) | Pyrrolopyridazine derivatives and related uses | |
| US20250115558A1 (en) | Pyridazine derivatives and related uses | |
| EA047011B1 (ru) | Производные сульфонилмочевины в качестве модуляторов nlrp3 инфламмасомы |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| E13 | Pre-grant limitation requested |
Free format text: ST27 STATUS EVENT CODE: A-2-3-E10-E13-LIM-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |